Leif Jan Eugen Andersson
Chief Executive Officer at Leif Andersson Consulting ApS
Network origin in Leif Jan Eugen Andersson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Aniona ApS
Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer.
4
| Private Company | Medical/Nursing Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Leif Jan Eugen Andersson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Founder Corporate Officer/Principal | |
ADDVISE GROUP AB | Medical Distributors | Director/Board Member | |
Karolinska Institutet | College/University | Corporate Officer/Principal | |
Ferrosan ApS
Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Other | Corporate Officer/Principal | |
FORCE Technology
FORCE Technology Miscellaneous Commercial ServicesCommercial Services FORCE Technology provides technical consultancy services. The firm offers knowledge and technologies in the form of improved products, processes, and methods. It focuses on the following areas: energy, oil and gas, maritime, manufacturing, infrastructure, and services. The company was founded in 1939 and is headquartered in Brondby, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Azign Bioscience AS
Azign Bioscience AS BiotechnologyHealth Technology Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004. | Biotechnology | Director/Board Member | |
University of London | College/University | Graduate Degree | |
Stockholm School of Economics | College/University | Graduate Degree | |
Technical University of Denmark | College/University | Graduate Degree | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Karolinska Investment Fund KB
Karolinska Investment Fund KB Investment ManagersFinance Karolinska Investment Fund KB is a healthcare-focused fund based in Stockholm. Targeted portfolio companies are pharmaceutical, biotechnology and medical technology companies located in Sweden. | Investment Managers | Founder | |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal | |
The Danish Academy of Technical Sciences | College/University | Corporate Officer/Principal | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Founder | |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
MOBERG PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Bok Holding A/S
Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member | |
DELTA A/S (Denmark)
DELTA A/S (Denmark) Miscellaneous Commercial ServicesCommercial Services DELTA A/S is a testing and consulting private company based in Hørsholm, Denmark. DELTA A/S operates as a testing and consulting Danish company. The CEO of the company is Per Hartlev. | Miscellaneous Commercial Services | Director/Board Member | |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Director/Board Member | |
Danish National Research Foundation | Director/Board Member | ||
Poseidon Pharmaceuticals A/S | Director/Board Member | ||
Alfta Rehab Center Holding AB | Director/Board Member | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Aktieselskabet af 20. November 2003 | Director/Board Member | ||
DELTA, Dansk, Elektronik, Lys & Akustik
DELTA, Dansk, Elektronik, Lys & Akustik Miscellaneous Commercial ServicesCommercial Services DELTA, Dansk, Elektronik, Lys & Akustik offers technical consultancy services in the fields of electronics, microelectronics, software technology, light, optics, acoustics, vibration and sensor systems. The company was founded by P.O. Pedersen in 1941 and is headquartered in Horsholm, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Danish Council for Independent Research | Director/Board Member | ||
SANA AB | Biotechnology | Founder Chairman Founder Founder Director/Board Member Chief Executive Officer Director/Board Member Founder | |
Delta Reader A/S | Chairman | ||
Ellegaard Göttingen Minipigs A/S
Ellegaard Göttingen Minipigs A/S Pharmaceuticals: MajorHealth Technology Ellegaard Göttingen Minipigs A/S is a private company based in Dalmose, Denmark that develops, breeds, and supplies Göttingen Minipigs for biomedical research worldwide. The Danish company's fundamental belief in quality, cooperation, respect, and animal welfare enables the development of safer and more effective medicines. Ellegaard Göttingen Minipigs supplies Göttingen Minipigs of all ages, weight groups, and both genders for biomedical research. The company's barrier facilities ensure breeding of Göttingen Minipigs of high quality and with a unique health status. Supporting and participating in scientific research activities involving Göttingen Minipigs is a fundamental part of the business foundation at Ellegaard Göttingen Minipigs. The CEO of the company is Lars Friis Mikkelsen. | Pharmaceuticals: Major | Director/Board Member | |
Lipopetide AB | Director of Finance/CFO | ||
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Biotechnology | Director/Board Member | |
2CUREX AB | Medical Specialties | Director/Board Member | |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Director/Board Member | |
Mpj Otc AB
Mpj Otc AB Pharmaceuticals: OtherHealth Technology Part of Moberg Pharma AB, Mpj Otc AB is a company that manufactures and distributes therapeutic medicines and personal products. | Pharmaceuticals: Other | Director/Board Member | |
Moberg Derma Incentives AB | Chairman | ||
ONCOZENGE AB | Pharmaceuticals: Major | Chairman | |
Synklino A/S
Synklino A/S BiotechnologyHealth Technology Synklino A/S develops a CMV-specific immunotoxin that aims to eliminate cytomegalovirus infections. | Biotechnology | Director/Board Member |
Statistics
International
Denmark | 31 |
Sweden | 18 |
United States | 3 |
United Kingdom | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 7 |
Commercial Services | 6 |
Finance | 4 |
Transportation | 2 |
Operational
Director/Board Member | 89 |
Corporate Officer/Principal | 28 |
Founder | 20 |
Chairman | 19 |
Chief Executive Officer | 18 |
Most connected contacts
- Stock Market
- Insiders
- Leif Jan Eugen Andersson
- Company connections